You plan to file a patent application for an invention that uses and/or claims a biological material. Do you need to deposit a sample of the biological material with a recognized depository institution? This article explores the strategic considerations for biological deposits to satisfy the regulations of patent offices in the United States and Europe.
Recent Posts
- CAFC Rules Patent Applications are Considered Pre-AIA Prior Art By Filing Date, Not Publication Date
- The Biden Administration Rolls the Dice on NIH Patent Licensing
- The PTAB’s 70% All-Claims Invalidation Rate Continues to Be a Source of Concern
- Novartis’ Entresto Patent Claims Revived by CAFC
- INTA Urges EUIPO Grand Board to Confirm Human Face Marks are Not Excluded from Trademark Registration